1245 related articles for article (PubMed ID: 31473156)
1. Gut Microbial Dysbiosis in the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies.
Wang L; Alammar N; Singh R; Nanavati J; Song Y; Chaudhary R; Mullin GE
J Acad Nutr Diet; 2020 Apr; 120(4):565-586. PubMed ID: 31473156
[TBL] [Abstract][Full Text] [Related]
2. Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome.
Wang Z; Xu CM; Liu YX; Wang XQ; Zhang L; Li M; Zhu SW; Xie ZJ; Wang PH; Duan LP; Zhu HQ
Chin Med J (Engl); 2019 Apr; 132(8):889-904. PubMed ID: 30958430
[TBL] [Abstract][Full Text] [Related]
3. Alterations of gut microbiota in patients with irritable bowel syndrome: A systematic review and meta-analysis.
Zhuang X; Xiong L; Li L; Li M; Chen M
J Gastroenterol Hepatol; 2017 Jan; 32(1):28-38. PubMed ID: 27300149
[TBL] [Abstract][Full Text] [Related]
4. Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis.
Shukla R; Ghoshal U; Dhole TN; Ghoshal UC
Dig Dis Sci; 2015 Oct; 60(10):2953-62. PubMed ID: 25784074
[TBL] [Abstract][Full Text] [Related]
5. Gut Bacterial Dysbiosis in Irritable Bowel Syndrome: a Case-Control Study and a Cross-Cohort Analysis Using Publicly Available Data Sets.
Kim GH; Lee K; Shim JO
Microbiol Spectr; 2023 Feb; 11(1):e0212522. PubMed ID: 36652592
[TBL] [Abstract][Full Text] [Related]
6. Gut fungal dysbiosis and altered bacterial-fungal interaction in patients with diarrhea-predominant irritable bowel syndrome: An explorative study.
Hong G; Li Y; Yang M; Li G; Qian W; Xiong H; Bai T; Song J; Zhang L; Hou X
Neurogastroenterol Motil; 2020 Nov; 32(11):e13891. PubMed ID: 32449259
[TBL] [Abstract][Full Text] [Related]
7. Fecal microbiota transplantation for irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials.
Wang M; Xie X; Zhao S; Ma X; Wang Z; Zhang Y
Front Immunol; 2023; 14():1136343. PubMed ID: 37275867
[TBL] [Abstract][Full Text] [Related]
8. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome.
Duboc H; Rainteau D; Rajca S; Humbert L; Farabos D; Maubert M; Grondin V; Jouet P; Bouhassira D; Seksik P; Sokol H; Coffin B; Sabaté JM
Neurogastroenterol Motil; 2012 Jun; 24(6):513-20, e246-7. PubMed ID: 22356587
[TBL] [Abstract][Full Text] [Related]
9. Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: A systematic review and meta-analysis.
Liu HN; Wu H; Chen YZ; Chen YJ; Shen XZ; Liu TT
Dig Liver Dis; 2017 Apr; 49(4):331-337. PubMed ID: 28179092
[TBL] [Abstract][Full Text] [Related]
10. Alterations of Gut Microbiota in Patients With Irritable Bowel Syndrome Based on 16S rRNA-Targeted Sequencing: A Systematic Review.
Duan R; Zhu S; Wang B; Duan L
Clin Transl Gastroenterol; 2019 Feb; 10(2):e00012. PubMed ID: 30829919
[TBL] [Abstract][Full Text] [Related]
11. Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome.
Mizuno S; Masaoka T; Naganuma M; Kishimoto T; Kitazawa M; Kurokawa S; Nakashima M; Takeshita K; Suda W; Mimura M; Hattori M; Kanai T
Digestion; 2017; 96(1):29-38. PubMed ID: 28628918
[TBL] [Abstract][Full Text] [Related]
12. Interplay between bile acid metabolism and microbiota in irritable bowel syndrome.
Dior M; Delagrèverie H; Duboc H; Jouet P; Coffin B; Brot L; Humbert L; Trugnan G; Seksik P; Sokol H; Rainteau D; Sabate JM
Neurogastroenterol Motil; 2016 Sep; 28(9):1330-40. PubMed ID: 27060367
[TBL] [Abstract][Full Text] [Related]
13. Feeling down? A systematic review of the gut microbiota in anxiety/depression and irritable bowel syndrome.
Simpson CA; Mu A; Haslam N; Schwartz OS; Simmons JG
J Affect Disord; 2020 Apr; 266():429-446. PubMed ID: 32056910
[TBL] [Abstract][Full Text] [Related]
14. Fecal bacteria can predict the efficacy of rifaximin in patients with diarrhea-predominant irritable bowel syndrome.
Li Y; Hong G; Yang M; Li G; Jin Y; Xiong H; Qian W; Hou X
Pharmacol Res; 2020 Sep; 159():104936. PubMed ID: 32470562
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiome signatures reflect different subtypes of irritable bowel syndrome.
Su Q; Tun HM; Liu Q; Yeoh YK; Mak JWY; Chan FK; Ng SC
Gut Microbes; 2023; 15(1):2157697. PubMed ID: 36573834
[TBL] [Abstract][Full Text] [Related]
16. The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation.
Mazzawi T; Lied GA; Sangnes DA; El-Salhy M; Hov JR; Gilja OH; Hatlebakk JG; Hausken T
PLoS One; 2018; 13(11):e0194904. PubMed ID: 30427836
[TBL] [Abstract][Full Text] [Related]
17. Gut Microbiota in Patients With Irritable Bowel Syndrome-A Systematic Review.
Pittayanon R; Lau JT; Yuan Y; Leontiadis GI; Tse F; Surette M; Moayyedi P
Gastroenterology; 2019 Jul; 157(1):97-108. PubMed ID: 30940523
[TBL] [Abstract][Full Text] [Related]
18. Increased Ileal Immunoglobulin A Production and Immunoglobulin A-Coated Bacteria in Diarrhea-Predominant Irritable Bowel Syndrome.
Liu Y; Yuan X; Li L; Lin L; Zuo X; Cong Y; Li Y
Clin Transl Gastroenterol; 2020 Mar; 11(3):e00146. PubMed ID: 32352710
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota profiles and the role of anti-CdtB and anti-vinculin antibodies in patients with functional gastrointestinal disorders (FGID).
Vasapolli R; Schulz C; Schweden M; Casèn C; Kirubakaran GT; Kirste KH; Macke L; Link A; Schütte K; Malfertheiner P
Eur J Clin Invest; 2021 Dec; 51(12):e13666. PubMed ID: 34390492
[TBL] [Abstract][Full Text] [Related]
20. Distinct Microbial Populations Exist in the Mucosa-associated Microbiota of Diarrhea Predominant Irritable Bowel Syndrome and Ulcerative Colitis.
Zhong W; Lu X; Shi H; Zhao G; Song Y; Wang Y; Zhang J; Jin Y; Wang S
J Clin Gastroenterol; 2019 Oct; 53(9):660-672. PubMed ID: 29210899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
